Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?
Lancet Oncol
.
2007 Mar;8(3):189-90.
doi: 10.1016/S1470-2045(07)70053-0.
Authors
Richard Greil
,
Hubert J Stein
PMID:
17329188
DOI:
10.1016/S1470-2045(07)70053-0
No abstract available
Publication types
Comment
Letter
MeSH terms
Esophageal Neoplasms / therapy*
Humans
Neoadjuvant Therapy*